16
Participants
Start Date
March 31, 2011
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
eculizumab
"* Eculizumab Induction 600mg IV every 7 days for 4 doses~* Eculizumab 900mg IV 7 days later~* Eculizumab Maintenance 900mg IV every 14 days for total of 26 weeks"
Yale University, New Haven
Collaborators (1)
Alexion Pharmaceuticals, Inc.
INDUSTRY
Sanjay Kulkarni
OTHER